Cargando…

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

BACKGROUND: Bevacizumab combined with chemotherapy produces clinical durable response in 25–30% of recurrent glioblastoma patients. This group of patients has shown improved survival and quality of life. The aim of this study was to investigate changes in gene expression associated with response and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urup, Thomas, Staunstrup, Line Mærsk, Michaelsen, Signe Regner, Vitting-Seerup, Kristoffer, Bennedbæk, Marc, Toft, Anders, Olsen, Lars Rønn, Jønson, Lars, Issazadeh-Navikas, Shohreh, Broholm, Helle, Hamerlik, Petra, Poulsen, Hans Skovgaard, Lassen, Ulrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395849/ https://www.ncbi.nlm.nih.gov/pubmed/28420326 http://dx.doi.org/10.1186/s12885-017-3251-3

Ejemplares similares

(18)F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma
por: Nedergaard, Mette Kjoelhede, et al.
Publicado: (2015)

Extracranial metastases in glioblastoma—Two case stories
por: Schou Nørøxe, Dorte, et al.
Publicado: (2018)

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
por: Poulsen, Hans Skovgaard, et al.
Publicado: (2014)

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas
por: Michaelsen, Signe Regner, et al.
Publicado: (2018)

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B
por: Staberg, Mikkel, et al.
Publicado: (2018)

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
por: Urup, Thomas, et al.
Publicado: (2020)

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
por: Bogetofte Barnkob, Mike, et al.
Publicado: (2022)

Expression and splicing mediate distinct biological signals
por: Dam, Søren Helweg, et al.
Publicado: (2023)

Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma
por: Frandsen, Simone, et al.
Publicado: (2019)

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
por: Michaelsen, Signe Regner, et al.
Publicado: (2013)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Most protein domains exist as variants with distinct functions across cells, tissues and diseases
por: Vitting-Seerup, Kristoffer
Publicado: (2023)

Alerting the immune system via stromal cells is central to the prevention of tumor growth
por: Issazadeh-Navikas, Shohreh
Publicado: (2013)

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
por: Michaelsen, Signe R, et al.
Publicado: (2018)

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study
por: Nørøxe, Dorte Schou, et al.
Publicado: (2019)

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro
por: Staberg, Mikkel, et al.
Publicado: (2016)

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
por: Abedi, Armita Armina, et al.
Publicado: (2021)

Editorial: Alternative Splicing in Health and Disease
por: Kahraman, Abdullah, et al.
Publicado: (2022)

Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-β knock-out mice
por: Matheu, Victor, et al.
Publicado: (2005)

Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation
por: Fougner, Vincent, et al.
Publicado: (2022)

spliceR: an R package for classification of alternative splicing and prediction of coding potential from RNA-seq data
por: Vitting-Seerup, Kristoffer, et al.
Publicado: (2014)

CAGEfightR: analysis of 5′-end data using R/Bioconductor
por: Thodberg, Malte, et al.
Publicado: (2019)

satuRn: Scalable analysis of differential transcript usage for bulk and single-cell RNA-sequencing applications
por: Gilis, Jeroen, et al.
Publicado: (2022)

The HOPX and BLBP landscape and gliogenic regions in developing human brain
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2023)

Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq)
por: Jaberi, Elham, et al.
Publicado: (2020)

VEGF-C as a putative therapeutic target in cancer
por: Michaelsen, Signe R., et al.
Publicado: (2019)

IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function
por: Ambjørn, Malene, et al.
Publicado: (2013)

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
por: Manresa-Arraut, Alba, et al.
Publicado: (2018)

Personalized B cell response to the Lactobacillus rhamnosus GG probiotic in healthy human subjects: a randomized trial
por: Bornholdt, Jette, et al.
Publicado: (2020)

Corrigendum: Neuronal IFN-beta–induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1(+)T(reg) cells
por: Liu, Yawei, et al.
Publicado: (2017)

Neuronal IFN-beta–induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1(+)T(reg) cells
por: Liu, Yawei, et al.
Publicado: (2017)

Replication Protein A (RPA) Mediates Radio-Resistance of Glioblastoma Cancer Stem-Like Cells
por: Pedersen, Henriette, et al.
Publicado: (2020)

UPF2-Dependent Nonsense-Mediated mRNA Decay Pathway Is Essential for Spermatogenesis by Selectively Eliminating Longer 3'UTR Transcripts
por: Bao, Jianqiang, et al.
Publicado: (2016)

DNMT1 regulates expression of MHC class I in post-mitotic neurons
por: Gustafsson, Julie Ry, et al.
Publicado: (2018)

ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation
por: Liu, Yawei, et al.
Publicado: (2020)

To respond or not to respond: exploring empathy-related psychological and structural brain differences between placebo analgesia responders and non-responders
por: Hartmann, Helena, et al.
Publicado: (2023)

Respondent
por: Mitchell, Samuel A.
Publicado: (1992)

To respond or not to respond, the recurring question in plant mechanosensitivity
por: Leblanc-Fournier, Nathalie, et al.
Publicado: (2014)

HelpResponder—System for the Security of First Responder Interventions
por: Rodriguez-Sanchez, M. Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_33hoksd5vsfd608sujr4q4qli5